CAS 132810-10-7: Blonanserin

Description: Blonanserin is an atypical antipsychotic medication primarily used in the treatment of schizophrenia. It functions as a dopamine D2 receptor antagonist and a serotonin 5-HT2A receptor antagonist, which contributes to its therapeutic effects in managing psychotic symptoms. The chemical structure of Blonanserin includes a piperazine moiety, which is common in many antipsychotic drugs, and it exhibits a unique profile of receptor binding that may lead to a lower incidence of extrapyramidal side effects compared to traditional antipsychotics. Blonanserin is typically administered orally and has been shown to improve both positive and negative symptoms of schizophrenia. Its pharmacokinetics indicate a moderate half-life, allowing for once-daily dosing in clinical practice. As with other antipsychotics, potential side effects may include weight gain, sedation, and metabolic changes, necessitating careful monitoring during treatment. Overall, Blonanserin represents a valuable option in the pharmacological management of schizophrenia, particularly for patients who may not respond adequately to other treatments.

Formula: C₂₃H₃₀FN₃

InChI: InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3

InChI key: InChIKey=XVGOZDAJGBALKS-UHFFFAOYSA-N

SMILES: FC=1C=CC(=CC1)C=2C=C(N=C3C2CCCCCC3)N4CCN(CC)CC4

Synonyms:

• 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine
• 2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine
• 2-(4-Ethylpiperazin-1-Yl)-4-(4-Fluorophenyl)-5,6,7,8,9,10-Hexahydrocycloocta[B]Pyridine
• Ad 5423
• Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(1-fluorophenyl)-5,6,7,8,9,10-hexahydro-
• Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-
• Lonasen
• Blonanserin

Blonanserin

CAS: 132810-10-7

• Formula: C₂₃H₃₀FN₃
• Purity: >98.0%(HPLC)
• Color and Shape: White to Almost white powder to crystal
• Molecular weight: 367.51

Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-

CAS: 132810-10-7

• Formula: C₂₃H₃₀FN₃
• Purity: 98.0%
• Color and Shape: Solid
• Molecular weight: 367.5028

Blonanserin

CAS: 132810-10-7

Blonanserin (AD-5423), approved in Japan (2008), is an atypical antipsychotic with fewer side effects like …

• Formula: C₂₃H₃₀FN₃
• Purity: 99.85%
• Color and Shape: Solid
• Molecular weight: 367.5

Blonanserin

CAS: 132810-10-7

• Purity: 99.9%
• Molecular weight: 367.5g/mol

Blonanserin

CAS: 132810-10-7

• Formula: C₂₃H₃₀FN₃
• Color and Shape: White To Off-White Solid
• Molecular weight: 367.51

Blonanserin

CAS: 132810-10-7

• Molecular weight: 367.5g/mol

Blonanserin-d8

CAS: 132810-10-7

• Formula: C₂₃H₂₂FN₃D₈
• Molecular weight: 375.56

Blonanserin

CAS: 132810-10-7

Applications A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic. References …

• Formula: C₂₃H₃₀FN₃
• Color and Shape: Neat
• Molecular weight: 367.50

Blonanserin

CAS: 132810-10-7

Please enquire for more information about Blonanserin including the price, delivery time and more detailed …

• Formula: C₂₃H₃₀FN₃
• Purity: Min. 95%
• Molecular weight: 367.5 g/mol